Related Experiment Videos
The new corticosteroids: are they effective and safe?
1Department of Dermatology, University Hospital, Leuven, Belgium.
Dermatologic Clinics
|January 1, 1993
Summary
New corticosteroids show potential for allergic reactions, with budesonide acting as a sensitizer. Further research is needed to determine if other new corticosteroids are also primary sensitizers and to develop less allergenic options.
Area of Science:
- Dermatology
- Allergology
- Pharmacology
Background:
- The safety of novel corticosteroids is not fully established.
- Budesonide is increasingly identified as an allergen and a primary sensitizer.
- Pre-marketing positive tests for other new corticosteroids suggest potential cross-sensitivity.
Purpose of the Study:
- To evaluate the allergenic potential of new corticosteroids.
- To investigate the primary sensitizing capacity of novel corticosteroid molecules.
- To inform the pharmaceutical industry on developing safer corticosteroid alternatives.
Main Methods:
- Clinical observation of patient reactions to new corticosteroids.
- Allergen testing, including patch testing.
- Analysis of pre-marketing sensitization data.
Main Results:
- Budesonide is a frequent allergen and a primary sensitizer.
- Cross-sensitivity is observed among new corticosteroids.
- The primary sensitizing potential of other new corticosteroids requires further investigation.
Conclusions:
- The safety profile of new corticosteroids, particularly regarding sensitization, needs further evaluation.
- Budesonide poses a risk of allergic reactions.
- Future corticosteroid development must prioritize minimizing allergenic potential alongside efficacy and reduced classic side effects.